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Introduction {#sec001}
============

Tuberculosis (TB) mainly affects the lungs with grave consequences unless treated appropriately in time. It is one of the leading causes of under-5 child mortality worldwide particularly in the WHO Southeast Asia and Africa regions \[[@pone.0224752.ref001]\]. Apart from mortality, a good number of children are at risk of developing TB each year in the 22 high-burden countries according to the prediction of a mathematical modelling study \[[@pone.0224752.ref002]\]. In 2017, an estimated one million children developed TB disease worldwide \[[@pone.0224752.ref003]\]. Bangladesh is one of the TB endemic countries where co-existence of malnutrition and tuberculosis is rampant \[[@pone.0224752.ref002], [@pone.0224752.ref004], [@pone.0224752.ref005]\]. The prevalence of *Mycobacterium tuberculosis* (MTB) infection in Bangladesh according to the tuberculin survey, 2007--2009 using a cut-off point of ≥8 mm was found to be 12.4% and 22.6% among children aged 5--9 years and 10--14 years, respectively \[[@pone.0224752.ref006]\].

Stunting or chronic malnutrition predisposes to TB as a result of reduced host defense due to the impairment of cell mediated immunity \[[@pone.0224752.ref007]\]. Data related to the outcome of MTB infection and disease on growth of young children is meager. To the best of our knowledge, no study findings have been reported comparing the growth pattern between tuberculin skin test (TST)-positive and TST-negative children. Moreover, the risk factors for TST positivity are mostly unexplored in the early stages of child growth and development.

The primary aim of our study was to assess the differences of linear and ponderal growth between TST-positive and TST-negative children from a disadvantaged urban community who underwent a nutrition intervention program and were screened for secondary causes of malnutrition. Moreover, we wanted to predict determinants of TST positivity from demographic and socioeconomic data collected at the time of enrollment of each participant.

Methods {#sec002}
=======

The participants screened for TB was originally recruited from a larger community-based study titled "The Bangladesh Environmental Enteric Dysfunction (BEED)" study. Children of 12--18 months' who were stunted (length-for-age Z score \[LAZ\] \<-2 standard deviations) or at risk of stunting (LAZ \<-1 to -2 standard deviations) met eligibility criterion for enrollment in the BEED study. The objectives of BEED study include development of a histological scoring system for the diagnosis of Environmental Enteric Dysfunction (EED), identifying novel non-invasive biomarkers of EED, measurement of correlation between EED score and anthropometric attainment, determining the pathogenetic role of gut microbiota in development of EED, and targeting possible biological pathways of EED for the future therapeutic interventions. Our objective of growth difference measurement between TST-positive and TST-negative participants will complement our study objectives by determining the role of chronic subclinical infection in children's growth parameters. As the objective of our analysis is different from the main BEED study, we have calculated the sample size required for this potential analysis. Sample size was calculated using the formula of a descriptive study: *n = Z*^*2*^ *p(1-p)/d*^*2*^ and found at least 163 participants are required for this type of screening program \[where, *n =* required sample size, *Z =* standard normal variant value for 95% confidence level (1.96), *p =* expected proportion of the condition (12.4% according to a tuberculin survey conducted in Bangladesh), and *d =* precision (0.05)\]. However, we screened 243 children and we believe the available sample will allow us to perform a case-control analysis between TST-positive and TST-negative participants, nested in the main BEED study.

EED and latent tuberculosis infection (LTBI) are both chronic infections apparently responsible for pediatric undernutrition. On site dietary supplementation was provided with one boiled egg and 150 mL of whole milk daily for 90 feeding days which added an additional 178 kilocalories, 11.1 g protein, and 11.5 g of fat to the daily diet of the participants. Participants also received one sachet of micronutrient sprinkles containing vitamins A and C, folic acid, iron, and zinc for 60 days. Moreover, every child received one dose of anthelmintic at the onset of nutritional intervention. In addition, treatment for intercurrent illness during intervention period was ensured from the Study Clinic. Several nutrition centers were established in the community to provide supplementation among the participants under direct supervision of the research assistants. The study protocol was approved by the Research Review Committee (RRC) and Ethical Review Committee (ERC) of International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b). More details in methodology and area of the study has been described elsewhere \[[@pone.0224752.ref008], [@pone.0224752.ref009]\].

The participants who failed to graduate to an expected LAZ level in spite of nutritional intervention were screened for TB and other diseases to find out secondary causes of malnutrition. Failure to graduate is defined as LAZ persisting \<-2 standard deviations for stunted and \<-1 standard deviation for at risk of stunting groups at the end of intervention. Screened children underwent a chest radiograph (CXR), TST, and physical examination for TB diagnosis. History of recent close contact (within past 12 months) and suggestive symptoms of TB were elicited through a careful interview of the mother. TST was administered using the Mantoux method to each of the children using tuberculin PPD 10 tuberculin units (TU)/0.1 mL (ARKRAY Healthcare Pvt. Ltd., Sachin, Gujarat, India) and the readings were recorded at 48--72 hours post administration in millimeter (mm). The diagnosis of TST positivity was confirmed through measuring a skin induration of ≥10 mm in diameter \[[@pone.0224752.ref010], [@pone.0224752.ref011]\]. TST is a highly specific screening and diagnostic tool to identify latent MTB infection and disease \[[@pone.0224752.ref012]--[@pone.0224752.ref014]\]. The principle of tuberculin test is based on delayed type of hypersensitivity reaction resulting from stimulation of already sensitized T-cells of a person infected with MTB or other atypical mycobacteria. The entire screening procedure with subsequent management of the participants is depicted in [Fig 1](#pone.0224752.g001){ref-type="fig"}.

![Outline of TB screening study.](pone.0224752.g001){#pone.0224752.g001}

Participants anthropometry (weight and length) was measured with scales (Seca GmbH & Co. KG., Hamburg, Germany) at pre- and post-intervention following standard operating procedures. During enrollment, data on mother's age, education, and occupation along with household's average monthly income and people/room used for sleeping were collected using a pre-tested questionnaire. Maternal occupation was dichotomized into housewife and the rest category. Average monthly household income was converted from Bangladeshi taka to USD (84.50 BDT = 1 USD) and analyzed as a continuous variable. Maternal age, education, and people/room for sleeping in the household were analyzed as a continuous variable in logistic regression.

The impact of TST positivity on growth was computed using paired samples t-test and multivariable linear regression. In paired t-test, mean differences of LAZ, WAZ, and WLZ between pre- and post-nutritional intervention were calculated to assess the impact of TST status on growth. Linear regression was used to construct a model to explore the independent effect of TST positivity on our outcome variables (Δlength-for-age Z score \[LAZ\], Δweight-for-age Z score \[WAZ\], and Δweight-for-length Z score \[WLZ\]). Covariates considered were sex (male or female) and post-intervention age. Outcome variables were calculated subtracting pre-intervention from post-intervention LAZ, WAZ, and WLZ. Covariates were first analyzed through univariate regression against our outcome variables. However, both the covariates along with TST outcome (positive or negative) were included in multivariable models irrespective of statistical significance and this was done due to their biological plausibility aiming to have an impact on growth parameters. The method was iterated for the three independent regression models for each of our three outcome variables (ΔLAZ, ΔWAZ, and ΔWLZ). All statistical analyses were computed using STATA version 15.1 (StataCorp LP, College Station, Texas, USA).

Multivariable logistic regression was employed to predict TST positivity at enrollment. The purpose behind this analysis was to identify sociodemographic factors of TST positivity. Eight covariates were sorted out for logistic regression to predict the presence of TST positivity at enrollment based on their relevance. Individual covariate was analyzed first to detect an association with TST positivity by means of univariate regression. Significant covariates which had a *p*-value of ≤0.25 were subsequently included in multivariable analysis.

Results {#sec003}
=======

Two hundred and forty-three participants' data were included in the analysis who completed nutritional intervention and had TB screened. The sociodemographic features at enrollment are outlined in [Table 1](#pone.0224752.t001){ref-type="table"}. The prevalence of TST positivity in our study was 11.9% (29/243). In stunted and at risk of stunting groups, the prevalence was 10.9% (13/119) and 12.9% (16/124), respectively \[[Fig 2](#pone.0224752.g002){ref-type="fig"}\]. TST-positive cases among male and female were 13.9% (16/115) and 10.2% (13/128), respectively \[[Fig 2](#pone.0224752.g002){ref-type="fig"}\]. Out of 29 TST-positive children, 10 were clinically diagnosed as pulmonary tuberculosis (PTB) following our national guidelines for the management of TB in children \[[@pone.0224752.ref010]\]. One child fulfilled the diagnostic criteria of PTB without TST positivity. Among the 11 children who were diagnosed as PTB, 6 were from at risk of stunting group and remaining children were from the stunted group. However, more female \[[@pone.0224752.ref007]\] than male \[[@pone.0224752.ref004]\] were found to have clinically diagnosed PTB.

10.1371/journal.pone.0224752.t001

###### Enrollment characteristics of the study participants based on tuberculin skin test (*n* = 243).

![](pone.0224752.t001){#pone.0224752.t001g}

  Parameter                                                  TST-negative (*n* = 214)                            TST-positive (*n* = 29)   *p*-value
  ---------------------------------------------------------- --------------------------------------------------- ------------------------- --------------------------------------------
  **Male**                                                   99 (46)[^a^](#t001fn001){ref-type="table-fn"}       16 (55)                   0.36[^x^](#t001fn005){ref-type="table-fn"}
  **At risk of stunting**                                    108 (50)                                            16 (55)                   0.63[^x^](#t001fn005){ref-type="table-fn"}
  **Age in months**                                          15 (13--17)[^b^](#t001fn002){ref-type="table-fn"}   15 (12--16)               0.34[^z^](#t001fn007){ref-type="table-fn"}
  **Weight in kg**                                           8.0 ± 0.9[^c^](#t001fn003){ref-type="table-fn"}     8.2 ± 0.9                 0.35[^y^](#t001fn006){ref-type="table-fn"}
  **Length in cm**                                           72.2 ± 3.0                                          72.0 ± 3.4                0.71[^y^](#t001fn006){ref-type="table-fn"}
  **LAZ**                                                    -2.22 ± 0.86                                        -2.23 ± 0.78              0.95[^y^](#t001fn006){ref-type="table-fn"}
  **WAZ**                                                    -1.86 ± 0.88                                        -1.67 ± 0.74              0.27[^y^](#t001fn006){ref-type="table-fn"}
  **WLZ**                                                    -1.05 ± 0.88                                        -0.78 ± 0.94              0.12[^y^](#t001fn006){ref-type="table-fn"}
  **Maternal age in years**                                  25 (21--29)                                         24 (20--26)               0.04[^z^](#t001fn007){ref-type="table-fn"}
  **Maternal education**                                     5 (1--7)                                            6 (5--8)                  0.01[^z^](#t001fn007){ref-type="table-fn"}
  **Mother as housewife**                                    154 (72)                                            26 (90)                   0.04[^x^](#t001fn005){ref-type="table-fn"}
  **Income in taka**[^d^](#t001fn004){ref-type="table-fn"}   12000 (10000--16000)                                12000 (10000--20000)      0.91[^z^](#t001fn007){ref-type="table-fn"}
  **People/room in home**                                    3 (3--4)                                            3 (3--4)                  0.91[^z^](#t001fn007){ref-type="table-fn"}

^a^ Count; percentage in parentheses (all such values)

^b^ Median; interquartile range in parentheses (all such values)

^c^ Mean ± standard deviation (all such values)

^d^ One United States dollar = 84.50 Bangladeshi taka

^x^ Pearson chi-square test

^y^ Two-sample t test with equal variances

^z^ Two-sample Wilcoxon rank-sum test

![Bar plots demonstrate the percentage of TST-positive and TST-negative patients stratified by enrollment group and gender.](pone.0224752.g002){#pone.0224752.g002}

In primary outcome measurement, we observed statistically significant LAZ and WAZ improvement among the TST-negative participants after completion of the nutritional intervention in paired samples t-test (t \[213\] = 2.1839, p = 0.03 for LAZ and t \[213\] = 2.4122, p = 0.01 for WAZ). However, in a subsample analysis, TST-positive participants without PTB showed statistically significant WAZ and WLZ improvement at the end of the intervention period in paired samples t-test (t \[[@pone.0224752.ref018]\] = 3.3487, p = 0.003 for WAZ and t \[[@pone.0224752.ref018]\] = 2.6062, p = 0.01 for WLZ). In linear regression, we did not find any statistically significant difference in LAZ, WAZ, and WLZ attainment during the intervention period between TST-positive and TST-negative participants. Moreover, TST positivity remained comparable for growth parameters (TST-positive coefficient \[95% CI\], *p*-value for ΔLAZ score −0.04 \[−0.15, 0.08\], 0.51; ΔWAZ score 0.04 \[−0.11, 0.18\], 0.62; and ΔWLZ score 0.09 \[−0.11, 0.29\], 0.37) after adjustment of age and sex of the participants in multivariable analyses. The details of the paired samples t-tests and multivariable linear regression analyses are enumerated in Tables [2](#pone.0224752.t002){ref-type="table"}--[4](#pone.0224752.t004){ref-type="table"}.

10.1371/journal.pone.0224752.t002

###### Analysis of growth differences between TST-positive and TST-negative participants using paired samples t-test.

![](pone.0224752.t002){#pone.0224752.t002g}

  Parameter   TST-positive (*n* = 29)   TST-negative (*n* = 214)                                                                     
  ----------- ------------------------- -------------------------- -------------- ------ -------------- -------------- ------------- ------
  **LAZ**     -2.23 ± 0.78              -2.23 ± 0.82               0.006 ± 0.28   0.90   -2.22 ± 0.86   -2.18 ± 0.80   0.04 ± 0.30   0.03
  **WAZ**     -1.67 ± 0.74              -1.58 ± 0.87               0.09 ± 0.42    0.26   -1.86 ± 0.88   -1.79 ± 0.85   0.06 ± 0.37   0.01
  **WLZ**     -0.78 ± 0.94              -0.68 ± 0.95               0.09 ± 0.59    0.39   -1.05 ± 0.88   -1.01 ± 0.89   0.03 ± 0.50   0.30

Data are mean ± standard deviation

10.1371/journal.pone.0224752.t003

###### Analysis of growth differences between TST-positive and clinical TB participants using paired samples t-test.

![](pone.0224752.t003){#pone.0224752.t003g}

  Parameter   TST-positive (*n* = 19)   Clinical TB (*n* = 10)                                                                      
  ----------- ------------------------- ------------------------ ------------- ------- -------------- -------------- -------------- ------
  **LAZ**     -2.13 ± 0.75              -2.06 ± 0.83             0.07 ± 0.29   0.32    -2.43 ± 0.85   -2.53 ± 0.73   -0.11 ± 0.25   0.21
  **WAZ**     -1.54 ± 0.80              -1.30 ± 0.88             0.24 ± 0.31   0.003   -1.91 ± 0.57   -2.11 ± 0.57   -0.20 ± 0.46   0.21
  **WLZ**     -0.70 ± 1.05              -0.44 ± 1.03             0.26 ± 0.44   0.01    -0.93 ± 0.72   -1.15 ± 0.55   -0.22 ± 0.72   0.35

Data are mean ± standard deviation

10.1371/journal.pone.0224752.t004

###### Relationship between tuberculin skin test and anthropometric attainment of children who underwent nutritional intervention.

![](pone.0224752.t004){#pone.0224752.t004g}

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Variables   Unadjusted Coefficient[^1^](#t004fn002){ref-type="table-fn"}\   *p*-value             Adjusted Coefficient[^2^](#t004fn003){ref-type="table-fn"}\   *p*-value             
              (95% CI[^3^](#t004fn004){ref-type="table-fn"})                                        (95% CI)                                                                            
  ----------- --------------------------------------------------------------- --------------------- ------------------------------------------------------------- --------------------- ------
  **ΔLAZ**    TST (+)                                                         -0.04 (-0.15, 0.08)   0.51                                                          -0.04 (-0.15, 0.08)   0.51

  Female      -0.02 (-0.10, 0.05)                                             0.54                  -0.02 (-0.10, 0.05)                                           0.52                  

  Age         0.003 (-0.01, 0.02)                                             0.70                  0.003 (-0.01, 0.02)                                           0.74                  

  **ΔWAZ**    TST (+)                                                         0.03 (-0.12, 0.17)    0.70                                                          0.04 (-0.11, 0.18)    0.62

  Female      0.01 (-0.08, 0.10)                                              0.82                  0.01 (-0.08, 0.11)                                            0.80                  

  Age         0.01 (-0.01, 0.03)                                              0.25                  0.01 (-0.01, 0.04)                                            0.23                  

  **ΔWLZ**    TST (+)                                                         0.06 (-0.14, 0.26)    0.55                                                          0.09 (-0.11, 0.29)    0.37

  Female      0.05 (-0.08, 0.18)                                              0.47                  0.05 (-0.08, 0.18)                                            0.43                  

  Age         0.05 (0.02, 0.08)                                               0.003                 0.05 (0.02, 0.08)                                             0.002                 
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

ΔLAZ, ΔWAZ, and ΔWLZ denote change in length-for-age, weight-for-age, and weight-for-length Z scores during the intervention period; TST (+) denotes tuberculin skin test positive; Age indicates post-intervention age in months

^1^ Univariate linear regression

^2^ Multivariable linear regression

^3^ Confidence interval

In a secondary analysis to predict TST positivity, we included participants age (*p* = 0.19), maternal age (*p* = 0.03), maternal education (*p* = 0.04), and maternal occupation (*p* = 0.05) \[for other than housewife; reference housewife\] in our final multivariable model. However, none of the covariates achieved statistical significance for the prediction of TST positivity in multivariable logistic regression model. The details of the logistic regression analyses are listed in [Table 5](#pone.0224752.t005){ref-type="table"}.

10.1371/journal.pone.0224752.t005

###### Predictors of TST positivity at enrollment (*n* = 243).

![](pone.0224752.t005){#pone.0224752.t005g}

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Variables                       Unadjusted OR[^1^](#t005fn001){ref-type="table-fn"}\   [^3^](#t005fn003){ref-type="table-fn"}*p*-value   Adjusted OR\        [^4^](#t005fn004){ref-type="table-fn"}*p*-value
                                  (95% CI[^2^](#t005fn002){ref-type="table-fn"})                                                           (95% CI)            
  ------------------------------- ------------------------------------------------------ ------------------------------------------------- ------------------- -------------------------------------------------
  **Age of the participants**                                                                                                                                  

  **(days)**                      0.99 (0.99, 1.00)                                      0.19                                              1.00 (0.99, 1.00)   0.24

  **Age of the mothers**                                                                                                                                       

  **(years)**                     0.91 (0.83, 0.99)                                      0.03                                              0.92 (0.84, 1.01)   0.08

  **Education of the mothers**                                                                                                                                 

  **(years)**                     1.12 (1.00, 1.24)                                      0.04                                              1.08 (0.96, 1.22)   0.18

  **Occupation of the mothers**                                                                                                                                

  **Housewife**                   Reference                                                                                                Reference           

  **Others**                      0.30 (0.09, 1.03)                                      0.05                                              0.38 (0.11, 1.33)   0.12
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^1^ Odds ratio

^2^ Confidence interval

^3^ Univariate logistic regression

^4^ Multivariable logistic regression

Discussion {#sec004}
==========

To our knowledge this is the first study which intended to estimate an impact of TST positivity on children's growth in response to a community-based nutritional intervention. We observed similar growth trajectories between TST-positive and TST-negative participants in response to our intervention. However, statistically significant LAZ and WAZ improvement in TST-negative children was indicative of the positive impact of nutritional intervention among them. TST-positivity is generally indicative of MTB infection with or without active TB disease. Although, numerous studies have reported an association between malnutrition and tuberculosis \[[@pone.0224752.ref007], [@pone.0224752.ref015], [@pone.0224752.ref016]\], it is difficult to ascertain whether malnutrition causes tuberculosis or vice versa. Malnutrition has a profound adverse impact on the immune system of our body which exhibits a crucial role against various pathogenic microbes. Moreover, malnutrition impairs cellular host defense mechanisms that protect from bacterial infection such as MTB \[[@pone.0224752.ref007]\]. On the other hand, tuberculosis decreases appetite of the affected child with an increase in metabolism leading to weight loss and subsequent malnutrition \[[@pone.0224752.ref015]\]. However, till date, studies failed to establish direct relationship between LTBI and malnutrition \[[@pone.0224752.ref007]\]. Our study identified the knowledge gap between the relationship of TST positivity and stunting to some extent. Improved growth velocity in absence of TST positivity and/or active PTB disease below the age of two years is a novel finding which may imply immense public health implications. Moreover, we were unable to ascertain household contact of most of the TST-positive and clinical PTB cases in our study. This observation indicates that a considerable number of undiagnosed adult TB cases may be still available in the community \[[@pone.0224752.ref017], [@pone.0224752.ref018]\]. Previous studies conducted in developing countries revealed a noteworthy proportion of children suffering from LTBI with or without identifiable smear-positive household pulmonary TB contact \[[@pone.0224752.ref006], [@pone.0224752.ref019], [@pone.0224752.ref020]\]. A case-control study in Guinea-Bissau reported a prevalence of 41% TST-positive patients among household TB exposed and 22% among non-exposed yielding a ratio of 1.48 (95% CI 1.37, 1.60) between them \[[@pone.0224752.ref019]\].

Previously numerous studies had documented detrimental impact of acute and chronic gastrointestinal infections on linear growth in the developing countries \[[@pone.0224752.ref021]--[@pone.0224752.ref023]\]. However, no impact of fever and respiratory infections on growth was identified \[[@pone.0224752.ref022]\]. Growth faltering of children has been detected in absence of obvious clinical manifestations of diarrhea but with the presence of enteropathogens in stool \[[@pone.0224752.ref024], [@pone.0224752.ref025]\]. A multi-country longitudinal cohort study conducted in developing countries including Bangladesh found significant growth faltering in respect of LAZ attainment among children aged two years with higher enteropathogen burden in non-diarrhoeal stool \[[@pone.0224752.ref024]\]. The same study also revealed lower consumption of energy and lack of protein rich diet intake was responsible for growth deficits in respect of both LAZ and WAZ attainment. Another case-control study conducted in Bangladeshi malnourished children less than two years of age suggests that enteropathogens had a significant effect on their growth \[[@pone.0224752.ref025]\]. Although nutritional intervention had a significant positive impact on the LAZ and WAZ outcome in the TST-negative children, the same intervention alone without definitive treatment failed to have sufficient impact for the TST-positive children. It is apparently evident from the study that treatment of children having LTBI with INH prophylaxis along with proper nutritional support is essential to reduce stunting in such children.

The distinctive strength of our study was its prospective design to assess the response of nutritional treatment among undernourished TST-positive and TST-negative children. We ascertained the TST status only after the intervention period during a routine screening of secondary causes of malnutrition. Moreover, a true intervention was ensured through directly observed therapy.

Our study had a few important limitations. First, we only enrolled stunted and at risk of stunting children which had limited the generalizability of our findings. Second, we did not assign a control group without nutritional intervention to ascertain the impact of the intervention on TST status. Finally, although our sample size was adequate for a descriptive study, it did not provide adequate power to our primary outcome analysis particularly in respect to the number of TST-positive cases.

Conclusion {#sec005}
==========

TST positivity was common among our study population who were stunted or at risk of stunting living in an underprivileged urban community setting. Our study findings on the basis of paired samples t-test noted a positive impact of nutritional intervention on growth parameters among TST-negative participants, although, we did not find this impact in linear regression. However, the preliminary observation underscores the importance of identifying and promptly treating source cases. This may help to reduce the exposure of children to TB source cases, thus may reduce TB and increase TST-negativity. Moreover, the observation re-emphasizes the importance of providing INH prophylaxis in all LTBI cases recommended by the WHO in order to reduce TB disease in children.

Supporting information {#sec006}
======================
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Reviewer \#1: Yes

Reviewer \#2: No
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4\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes
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5\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: This study has aimed to explore the determinants of TST positivity in children. TB screening as one of the secondary causes of malnutrition was performed on 243 stunted or at-risk of stunting children. Screened children underwent a chest radiograph (CXR), TST, and physical examination for TB diagnosis.

The current study has examined the growth differences between TST-positive and TST-negative undernourished children aged 12 to 18 months who received nutritional intervention prospectively for 90 feeding days.

This is the first study which intended to estimate an impact of TST positivity on children's growth in response to a community-based nutritional intervention.

Although the current study was designed towards understanding the tuberculosis in malnutrition children, unexpectedly, nothing significant found in the study.

This study should be published in a medical journal for reporting the relationship between tuberculosis and malnutrition in children, but the study is not fit for an international peer-reviewed journal like PLOS ONE.

Reviewer \#2: The manuscript presented no new significant findings. Moreover, it is already known fact to use INH prophylaxis in paediatric populations. The control group lacks significant number of cases to justify and establish the hypothesis raised. The study also document several limitations, raising questions on study design and case controlling. Outcome is not justified significantly. It is encouraged to increase the study participants and include more objectives rather than only nutritional aspects in paediatric populations.
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6\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.
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Reviewers' comments to PLOS ONE questions and to the author with author responses:

Question 1: Is the manuscript technically sound, and do the data support the conclusions?

Reviewer \#1: Yes

Response: Thank you.

Reviewer \#2: No

Response: Thank you. We have now revised the conclusion in the text for better clarity and hope revised conclusion will qualify for the publication.

Question 2: Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

Response: Thank you.

Reviewer \#2: Yes

Response: Thank you.

Question 3: Have the authors made all data underlying the findings in their manuscript fully available?

Reviewer \#1: Yes

Response: Thank you.

Reviewer \#2: No

Response: Thank you. The full dataset was uploaded during the manuscript submission process.

Question 4: Is the manuscript presented in an intelligible fashion and written in standard English?

Reviewer \#1: Yes

Response: Thank you.

Reviewer \#2: Yes

Response: Thank you.

5\. Review Comments to the Author

Reviewer \#1: This study has aimed to explore the determinants of TST positivity in children. TB screening as one of the secondary causes of malnutrition was performed on 243 stunted or at-risk of stunting children. Screened children underwent a chest radiograph (CXR), TST, and physical examination for TB diagnosis.

The current study has examined the growth differences between TST-positive and TST-negative undernourished children aged 12 to 18 months who received nutritional intervention prospectively for 90 feeding days.

This is the first study which intended to estimate an impact of TST positivity on children's growth in response to a community-based nutritional intervention.

Although the current study was designed towards understanding the tuberculosis in malnutrition children, unexpectedly, nothing significant found in the study.

This study should be published in a medical journal for reporting the relationship between tuberculosis and malnutrition in children, but the study is not fit for an international peer-reviewed journal like PLOS ONE.

Response: Thanks for your overall positive comments. Our primary objective was to examine the growth differences between TST-positive and TST-negative undernourished children aged 12 to 18 months who received nutritional intervention prospectively for 90 feeding days in the parent Bangladesh Environmental Enteric Dysfunction (BEED) study. We observed statistically significant improvement of length for age Z-score (LAZ) and weight for age Z-score (WAZ) among the TST-negative participants at the end of intervention period. Our secondary objective was to explore the determinants of TST positivity at enrollment. We observed several factors (maternal age, education, and occupation) that were significantly associated with TST positivity in our study children during univariate logistic regression analysis. However, as you mentioned, multivariable logistic regression failed to identify any association of those factors with TST positivity. As you rightly noticed this is the first study which is intended to estimate an impact of TST positivity on children's growth in response to a community-based nutritional intervention, and importantly, the objectives of the study are aligned with the methods, results, and conclusion, we feel the revised manuscript bears merit for publication in the PLOS ONE.

Reviewer \#2: The manuscript presented no new significant findings. Moreover, it is already known fact to use INH prophylaxis in paediatric populations. The control group lacks significant number of cases to justify and establish the hypothesis raised. The study also documents several limitations, raising questions on study design and case controlling. Outcome is not justified significantly. It is encouraged to increase the study participants and include more objectives rather than only nutritional aspects in paediatric populations.

Response: Thank you. Improved growth velocity in absence of TST positivity and/or active PTB disease below the age of two years is a novel finding which may imply immense public health implications. Moreover, we were unable to ascertain household contact of most of the TST-positive and clinical PTB cases in our study. This observation indicates that a considerable number of undiagnosed adult TB cases may be still available in the community. Contact tracing system is not well conducted in developing countries with a high burden of tuberculosis cases. Thus, our finding underscores the importance to screen the undernourished children for latent pulmonary tuberculosis with or without smear-positive adult household contact who may be benefited from INH prophylaxis, already recommeneded by the WHO. We have revised our conclusion on the basis of your recommendation.

Now, we also calculated the sample size using the formula of a descriptive study: n = Z² p(1-p)/d² and found 163 participants is sufficient for this type of screening program \[where, n = required sample size, Z = standard normal variant value for 95% confidence level (1.96), p = expected proportion of the condition (12.4% according to a tuberculin survey conducted in Bangladesh), and d = precision (0.05)\]. However, we screened 243 children and we believe the available sample will allow us to perform a case-control analysis between TST-positive and TST-negative participants, nested in the main BEED study. We have incorporated this sample size calculation in the text on page 4.
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